comparemela.com

Latest Breaking News On - Soleus capital management - Page 1 : comparemela.com

Institutional investors own a significant stake of 39% in IRadimed Corporation (NASDAQ:IRMD)

Key Insights Institutions' substantial holdings in IRadimed implies that they have significant influence over the.

Roger susiNine ten capital managementIradimed corporationTen capital managementSoleus capital managementNsider ownershipShare priceHare registry

Form SC 13G/A Axogen, Inc Filed by: Soleus Capital Master Fund, L P

Form SC 13G/A Axogen, Inc Filed by: Soleus Capital Master Fund, L P
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cayman islandsUnited statesGuy levySoleus capitalClassification of members the groupSoleus capital master fundNotice of dissolution groupSecurities exchangeInvestment companyPrincipal business officeMaster fundSoleus capital groupLp master fundAxogen incExchange commission onSecurities exchange act

Celcuity Inc (NASDAQ:CELC) has caught the attention of institutional investors who hold a sizeable 33% stake

Key Insights Significantly high institutional ownership implies Celcuity's stock price is sensitive to their trading.

Brian sullivanVr adviserCelcuity incSoleus capital managementInstitutional ownershipElcuity incNsider ownership

ESSA Pharma Inc s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains

Key Insights Given the large stake in the stock by institutions, ESSA Pharma's stock price might be vulnerable to their.

Pharma incBellevue asset managementSoleus capital managementEssa pharmaInstitutional investorsSsa pharma incNsider ownershipHedge funds investorsHedge funds

With 64% institutional ownership, C4 Therapeutics, Inc (NASDAQ:CCCC) is a favorite amongst the big guns

Key Insights Given the large stake in the stock by institutions, C4 Therapeutics' stock price might be vulnerable to.

T rowe price group incTherapeutics incWasatch advisorsRowe price groupSoleus capital management

vimarsana © 2020. All Rights Reserved.